Darusentan is a selective endothelin ETA receptor antagonist. It is being evaluated as a treatment for congestive heart failure and hypertension.
Darusentan is a selective endothelin ETA receptor antagonist. It is being evaluated as a treatment for congestive heart failure and hypertension.
For the treatment of congestive heart failure and hypertension.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.